| 12459922 |
PARP7 inhibitors |
Jayaraman Chandrasekhar, Jonah J. Chang, Kevin S. Currie, Stephen D. Holmbo, Jesse M. Jacobsen +8 more |
2025-11-04 |
|
| 12053462 |
Quinoline derivatives |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more |
2024-08-06 |
$110,474,000 |
| 12054490 |
Diacylglycerol kinase modulating compounds |
Masaaki Sawa, Mai Arai, Ryoko Nakai, Hirokazu Matsumoto, Jonathan William Medley +2 more |
2024-08-06 |
$110,474,000 |
| 11976072 |
Diacylglycerol kinase modulating compounds |
Julian A. Codelli, Michael Graupe, Juan A. Guerrero, Stephen D. Holmbo, Tetsuya Kobayashi +5 more |
2024-05-07 |
$81,908,000 |
| 11932634 |
Diacylglycerol kinase modulating compounds |
Michael Graupe, Juan A. Guerrero, Stephen D. Holmbo, Jesse M. Jacobsen, Tetsuya Kobayashi +3 more |
2024-03-19 |
$231,549,000 |
| 11926628 |
Diacylglyercol kinase modulating compounds |
Julian A. Codelli, Michael Graupe, Juan A. Guerrero, Jesse M. Jacobsen, Tetsuya Kobayashi +4 more |
2024-03-12 |
$163,951,000 |
| 11845723 |
Diacylglycerol kinase modulating compounds |
Masaaki Sawa, Mai Arai, Ryoko Nakai, Hirokazu Matsumoto, Catherine Pugh +15 more |
2023-12-19 |
$116,955,000 |
| 11578069 |
Compounds for inhibition of α4 β7 integrin |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Kevin S. Currie +7 more |
2023-02-14 |
$213,129,000 |
| 11224600 |
Compounds for inhibition of alpha 4 beta 7 integrin |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more |
2022-01-18 |
$211,525,000 |
| 11179383 |
Compounds for inhibition of α4β7 integrin |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more |
2021-11-23 |
$216,502,000 |
| 11174256 |
Imidazopyridine derivatives |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more |
2021-11-16 |
$422,244,000 |
| 11116760 |
Quinoline derivatives |
Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more |
2021-09-14 |
$147,264,000 |
| 11021467 |
Phosphatidylinositol 3-kinase inhibitors |
Shaopei Cai, Zhimin Du, Musong Kim, Jennifer A. Loyer-Drew, Devan Naduthambi +7 more |
2021-06-01 |
$494,660,000 |
| 10479770 |
Phosphatidylinositol 3-kinase inhibitors |
Jayaraman Chandrasekhar, Devan Naduthambi, Stephane Perreault, Gary Phillips, Kassandra F. Sedillo +5 more |
2019-11-19 |
$392,391,000 |
| 10308639 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Joshua A. Kaplan, Stephane Perreault, Barton W. Phillips, Gary Phillips +2 more |
2019-06-04 |
$121,883,000 |
| 10227350 |
Phosphatidylinositol 3-kinase inhibitors |
Jayaraman Chandrasekhar, Stephane Perreault, Gary Phillips, Nicholas Alexander Till, Jennifer Treiberg |
2019-03-12 |
$422,771,000 |
| 10221197 |
Phosphatidylinositol 3-kinase inhibitors |
Zhimin Du, Jerry Evarts, Joshua A. Kaplan, Musong Kim, Devan Naduthambi +8 more |
2019-03-05 |
$131,246,000 |
| 10214519 |
Phosphatidylinositol 3-kinase inhibitors |
Jayaraman Chandrasekhar, Julian A. Codelli, Devan Naduthambi, Stephane Perreault, Gary Phillips +4 more |
2019-02-26 |
$422,217,000 |
| 9765060 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Joshua A. Kaplan, Musong Kim, Devan Naduthambi, Stephane Perreault +4 more |
2017-09-19 |
$522,566,000 |
| 9266878 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Jennifer Treiberg, Stephane Perreault, Arthur Yeung, Lafe J. Purvis, II +1 more |
2016-02-23 |
|
| 9221795 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Joshua A. Kaplan, Musong Kim, Stephane Perreault, Gary Phillips +2 more |
2015-12-29 |
$383,266,000 |
| 9029384 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Joshua A. Kaplan, Jennifer Treiberg, Stephane Perreault, Gary Phillips |
2015-05-12 |
|
| 9018221 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Jennifer Treiberg, Stephane Perreault, Arthur Yeung, Lafe J. Purvis, II +1 more |
2015-04-28 |
|
| 7868026 |
Therapeutic compounds |
Mitchell David Nambu, Brian D. Patterson, Sylvie Sakata, John Howard Tatlock |
2011-01-11 |
$282,769,000 |
